v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2026
Cash flows from operating activities:    
Net income (loss) $ (42,482) $ 2,634,541
Adjustments to reconcile net income (loss) to net cash used in operating activities    
Payment of expenses via promissory note 10,420
Income earned on marketable securities held in Trust Account (3,067,637)
Changes in operating assets and liabilities:    
Prepaid expenses (32,350)
Long-term prepaid insurance 37,500
Accrued expenses 32,062 211,877
Net cash used in operating activities (216,069)
Cash flows from financing activities:    
Proceeds for founder shares 25,000
Advances from Sponsor 596,740
Repayment of Working Capital Note (100,000)
Net cash provided by financing activities 25,000 496,740
Net change in cash and cash equivalents 25,000 280,671
Cash and cash equivalents, beginning of the period 389,108
Cash and cash equivalents, end of the period 25,000 669,779
Supplemental disclosure of cash flow information:    
Deferred offering costs included in accrued offering costs 169,313
Non-cash reclassification of advances from Sponsor to Working Capital Note $ 996,740